About us

Developing Next generation Resorbable Embolics

Instylla, Inc. is a privately held company based in Bedford, MA, focused on developing novel resorbable embolic agents to advance interventional radiology, with initial clinical applications in interventional oncology. Instylla was founded in 2017 by Incept LLC and is funded by several leading venture capital groups.

The company’s flagship product, Embrace™ Hydrogel Embolic System, is FDA-approved for hypervascular tumor embolization and offers controlled, targeted, and persistent embolization.

Restoring life, hope, and joy to the world’s sickest patients by materializing novel embolization solutions to improve outcomes.

Our Team

Sean Boyle

CEO

Ray Lareau

CTO

David Inman

CFO

Nathan Rhatigan

Senior Vice President of Sales

Amita Shah

Vice President of Quality and Regulatory

Lynn Morrison

Vice President of Clinical Affairs

Rashmi Prasad

Senior Director of Marketing

Amarpreet Sawhney, Ph.D.

FOUNDER AND CHAIRMAN
INSTYLLA, INC.

Sean Boyle, MBA

CEO
INSTYLLA, INC.

Fred Khosravi, M.S.

CHAIRMAN AND CEO IMPERATIVE CARE

Tasneem Dohadwala, M.S., MBA

FOUNDING PARTNER EXCELESTAR VENTURES

Sean J. Cheng, PhD

MANAGING DIRECTOR
ASCENSION VENTURES

Darshana Zaveri, M.S., MBA

FOUNDER AND MANAGING PARTNER CATALYST HEALTH VENTURES

Henry Chen, M.S., J.D.

FOUNDING AND MANAGING PARTNER DELOS CAPITAL

Daniel Davis, A.B.

CHIEF STRATEGY OFFICER
IMPERATIVE CARE

Karen T. Brown

WEILL CORNELL/ NEW YORK HOSPITAL

Thomas DiBartholomeo

YALE – NEW HAVEN HOSPITAL

Eric Gandras

NORTH SHORE UNIVERSITY HOSPITAL

Ripal Gandhi

MIAMI CARDIAC & VASCULAR INSTITUTE

Suvranu Ganguli

BOSTON MEDICAL CENTER

Jafar Golzarian

NORTH STAR VASCULAR AND INTERVENTIONAL

Michael Soulen

UNIVERSITY OF PENNSYLVANIA

Joshua Weintraub

COLUMBIA
PRESBYTERIAN HOSPITAL

Sean Boyle

CEO
A seasoned senior executive with over 15 years of leadership experience in the medical device industry, Sean Boyle brings a proven history of driving transformative growth across diverse business units. His career has been defined by building high-performing teams, advancing commercial readiness and execution, and delivering operational excellence. Before joining Instylla, Sean served as Vice President and General Manager of Oncology at Becton Dickinson, where he oversaw a global portfolio of nearly $1 billion in revenue.

Raymond Lareau

CTO

With a concentration in interventional radiology and oncology, Ray Lareau has over 25 years of experience in developing and commercializing innovative medical devices. Prior to joining Instylla in 2017, he was President and COO of High Performance Medical Solutions, a division of Hitachi America. He has also held positions of increasing responsibility in both operations and product development at Boston Scientific, Navilyst Medical, AngioDynamics, and Vortex Medical. Ray has over 30 issued and pending patents spanning short-term and implantable technologies. He holds a B.S. and M.S. in Plastics Engineering.

David Inman

CFO

With a focus on finance, accounting, and global commercial strategy, Dave Inman brings over 25 years of experience in the medical device industry.  Prior to joining Instylla, Dave held several senior finance roles at Boston Scientific and Haemonetics, where he played key roles in global financial strategy and supported multiple business units through expansion, integration, and operational optimization.  His expertise spans corporate finance, fundraising, strategic planning, and financial operations.  More recently, he was VP of Finance at Augmenix (sold to Boston Scientific), and CFO at DYSIS Medical (sold to Apgar Danmark A/S).  Dave holds a BA in Economics from the University of Pennsylvania and an MBA in Finance and Strategic Management from The Wharton School.

Nathan Rhatigan

Senior Vice President of Sales
Nathan Rhatigan is an accomplished commercial executive with nearly two decades of experience driving growth, building high-performing teams, and expanding market adoption across the medical device and minimally invasive therapeutics sectors. Throughout his career, Nathan has led organizations through pivotal scaling phases, combining strategic clarity with a leadership style rooted in collaboration, accountability, and deep customer understanding.

Before joining Instylla, Nathan served as U.S. Director of Vascular Sales at Balt, where he launched and built the company’s vascular division into a profitable, high-growth business. Nathan was instrumental in development and commercialization of their flagship coil implant for vessel occlusion. 
 
Nathan previously held commercial leadership roles at Penumbra, Johnson & Johnson, Medtronic, and VWR. His ability to build trusted, long-term partnerships with physicians, KOLs, and health system stakeholders has been a defining factor in his sustained success.

Amita Shah

VP OF QUALITY AND REGULATORY

Amita Shah has over 28 years of experience in regulatory and quality for cardiovascular, neurological and implantable medical devices. She has worked for ConforMIS, Confluent Surgical, Hemasure, and CR Bard Vascular/Cardiology where she authored and successfully cleared more than 25 510ks and participated in the PMA approval process. Amita has an M.S. in Chemistry.

Lynn Morrison

VP OF CLINICAL AFFAIRS
Lynn Morrison has over 30 years of experience in clinical affairs for cardiovascular medical devices. She has worked in the cardiac catheterization laboratory as a licensed Cardiovascular Technologist, and for the medical device companies of ACS/Guidant, Avantec Vascular and Elixir Medical, designing and executing clinical studies enrolling more than 4000 patients worldwide. Lynn has a Masters in Public Health (MPH).

Rashmi Prasad

Senior Director of Marketing

Rashmi Prasad leads global marketing strategy at Instylla as the company advances the commercialization of its resorbable embolic platform in 2026. She brings nearly two decades of experience in the medical device industry across upstream, downstream, and technical marketing roles, including leadership positions at Boston Scientific/Augmenix, Philips, and Draeger. Since joining Instylla in 2020, she has driven the company’s go-to-market strategy and strengthened its market presence. Rashmi holds a Master of Science from the University of Utah and a Bachelor of Engineering from MS Ramaiah Institute of Technology, where she graduated as valedictorian.